Cross-Neutralizing Breadth and Longevity Against SARS-CoV-2 Variants After Infections.
Kurahashi Y, Sutandhio S, Furukawa K, Tjan LH, Iwata S, Sano S, Tohma Y, Ohkita H, Nakamura S, Nishimura M, Arii J, Kiriu T, Yamamoto M, Nagano T, Nishimura Y, Mori Y.
Kurahashi Y, et al. Among authors: furukawa k.
Front Immunol. 2022 Feb 24;13:773652. doi: 10.3389/fimmu.2022.773652. eCollection 2022.
Front Immunol. 2022.
PMID: 35281007
Free PMC article.